STADA Arzneimittel AG, DE0007251803

STADA Arzneimittel AG, DE0007251803

05.10.2018 - 14:19:07

STADA Arzneimittel AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Notification of Major Holdings

1. Details of issuer STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Germany 2. Reason for notification X Acquisition/disposal of shares with voting rights   Acquisition/disposal of instruments   Change of breakdown of voting rights X Other reason:Exercise of financial instruments 3. Details of person subject to the notification obligation Name: City and country of registered office: Mr Paul E. Singer,Date of birth: 22 Aug 1944 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.  5. Date on which threshold was crossed or reached: 01 Oct 2018 6. Total positions   % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer Resulting situation 12.06 % 0.00 % 12.06 % 62342440 Previous notification 3.60 % 11.64 % 15.24 % / 7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 33, 34 WpHG) ISIN absolute in %   direct (Sec. 33 WpHG) indirect (Sec. 34 WpHG) direct (Sec. 33 WpHG) indirect (Sec. 34 WpHG) DE0007251803 7521209 % 12.06 % Total 7521209 12.06 % b.1. Instruments according to Sec. 38 para. 1 No. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % %     Total % b.2. Instruments according to Sec. 38 para. 1 No. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % %       Total % 8. Information in relation to the person subject to the notification obligation  Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more) Paul E. Singer % % % Braxton Associates, Inc. % % % Elliott Capital Advisors, L.P. % % % Hambledon, Inc. % % % Elliott International, L.P. 8,20 % % 8,20 %   Paul E. Singer % % % Elliott Asset Management LLC % % % Elliott Capital Advisors, L.P. % % % Hambledon, Inc. % % % Elliott International, L.P. 8,20 % % 8,20 %   Paul E. Singer % % % Elliott Capital Advisors, L.P. % % % Hambledon, Inc. % % % Elliott International, L.P. 8,20 % % 8,20 %   Paul E. Singer % % % Elliott Advisors GP, LLC % % % Elliott Associates, L.P. % % % The Liverpool Limited Partnership 3,86 % % %   Paul E. Singer % % % Elliott Advisors GP, LLC % % % Elliott Associates, L.P. % % % Liverpool Associates, Ltd. % % % The Liverpool Limited Partnership 3,86 % % %   Paul E. Singer % % % Elliott Special GP, LLC % % % Elliott Associates, L.P. % % % The Liverpool Limited Partnership 3,86 % % %   Paul E. Singer % % % Elliott Special GP, LLC % % % Elliott Associates, L.P. % % % Liverpool Associates, Ltd. % % % The Liverpool Limited Partnership 3,86 % % %   Paul E. Singer % % % Braxton Associates, Inc. % % % Elliott Capital Advisors, L.P. % % % Elliott Special GP, LLC % % % Elliott Associates, L.P. % % % The Liverpool Limited Partnership 3,86 % % %   Paul E. Singer % % % Braxton Associates, Inc. % % % Elliott Capital Advisors, L.P. % % % Elliott Special GP, LLC % % % Elliott Associates, L.P. % % % Liverpool Associates, Ltd. % % % The Liverpool Limited Partnership 3,86 % % %   Paul E. Singer % % % Braxton Associates, Inc. % % % Elliott Capital Advisors, L.P. % % % Elliott Associates, L.P. % % % The Liverpool Limited Partnership 3,86 % % %   Paul E. Singer % % % Braxton Associates, Inc. % % % Elliott Capital Advisors, L.P. % % % Elliott Associates, L.P. % % % Liverpool Associates, Ltd. % % % The Liverpool Limited Partnership 3,86 % % %   Paul E. Singer % % % Elliott Capital Advisors, L.P. % % % Elliott Special GP, LLC % % % Elliott Associates, L.P. % % % The Liverpool Limited Partnership 3,86 % % %   Paul E. Singer % % % Elliott Capital Advisors, L.P. % % % Elliott Special GP, LLC % % % Elliot Associates, L.P. % % % Liverpool Associates, Ltd. % % % The Liverpool Limited Partnership 3,86 % % %   Paul E. Singer % % % Elliott Capital Advisors, L.P. % % % Elliott Associates, L.P. % % % The Liverpool Limited Partnership 3,86 % % %   Paul E. Singer % % % Elliott Capital Advisors, L.P. % % % Elliott Associates, L.P. % % % Liverpool Associates, Ltd. % % % The Liverpool Limited Partnership 3,86 % % %   Paul E. Singer % % % Elliott Asset Management LLC % % % Elliott Capital Advisors, L.P. % % % Elliott Special GP, LLC % % % Elliott Associates, L.P. % % % The Liverpool Limited Partnership 3,86 % % %   Paul E. Singer % % % Elliott Asset Management LLC % % % Elliott Capital Advisors, L.P. % % % Elliott Special GP, LLC % % % Elliott Associates, L.P. % % % Liverpool Associates, Ltd. % % % The Liverpool Limited Partnership 3,86 % % %   Paul E. Singer % % % Elliott Asset Management LLC % % % Elliott Capital Advisors, L.P. % % % Elliott Associates, L.P. % % % The Liverpool Limited Partnership 3,86 % % %   Paul E. Singer % % % Elliott Asset Management LLC % % % Elliott Capital Advisors, L.P. % % % Elliott Associates, L.P. % % % Liverpool Associates, Ltd. % % % The Liverpool Limited Partnership 3,86 % % %   Paul E. Singer % % % Elliott International Capital Advisors, Inc. 8,20 % % 8,20 % 9. In case of proxy voting according to Sec. 34 para. 3 WpHGDate of general meeting: Holding position after general meeting: % (equals voting rights) 10. Other explanatory remarks: 

05.10.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel

Germany Internet: www.stada.de   End of News DGAP News Service

730619  05.10.2018 

@ dgap.de